HOME arrow News & PR

News & PR

RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S.

2015.04.16
RegeneRx JV Retains Ora, Inc. to Conduct Phase 3 Trial for NK and Phase 2b/3 Trial for Dry Eye Syndrome in U.S.
(if you want to view the body of article, click on the bottom link)
http://www.bloomberg.com/article/2015-04-16/acoLx_EIK6_M.html